Tango Therapeutics grants new hire stock option for 146,500 shares at $22.35

• Tango Therapeutics granted inducement equity awards effective Sept. 1, 2026 to a new employee under its 2023 Inducement Plan.
• A non-qualified stock option covers 146,500 shares with an exercise price of $22.35 per share.
• Option vests 25% on the first anniversary of the start date, then monthly in 1/36 increments, subject to continued employment.
• Grant also includes 40,000 restricted stock units vesting in three equal annual installments, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609031605PRIMZONEFULLFEED9821258) on September 03, 2026, and is solely responsible for the information contained therein.